Assignee
PHARNEXT
FR·44 granted patents·17 pending applications·162 citations·filing 2010–2023
Top patents by PatentIndex Score
61 records- 0197US9566275B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2016·Granted Feb 14, 2017·13 cites·14 claims
- 0296US9393241B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2014·Granted Jul 19, 2016·14 cites·11 claims
- 0396US9241933B2Compositions for treating amyotrophic lateral sclerosisPHARNEXT·Filed 2014·Granted Jan 26, 2016·16 cites·16 claims
- 0494US9427436B1Compositions for treating CMT and related disordersPHARNEXT·Filed 2016·Granted Aug 30, 2016·14 cites·5 claims
- 0594US8741886B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2012·Granted Jun 3, 2014·20 cites·17 claims
- 0693US8865769B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2012·Granted Oct 21, 2014·15 cites·10 claims
- 0790US10342784B2Compositions for treating amyotrophic lateral sclerosisPHARNEXT·Filed 2018·Granted Jul 9, 2019·2 cites·16 claims
- 0890US10322101B2Therapeutic approaches for treating CMT and related disordersPHARNEXT·Filed 2018·Granted Jun 18, 2019·2 cites·9 claims
- 0990US10045971B2Compositions for treating amyotrophic lateral sclerosisPHARNEXT·Filed 2016·Granted Aug 14, 2018·3 cites·15 claims
- 1089US9636316B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2015·Granted May 2, 2017·5 cites·15 claims
- 1189US9144558B2Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2014·Granted Sep 29, 2015·8 cites·42 claims
- 1288US10092554B2Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose levelPHARNEXT·Filed 2015·Granted Oct 9, 2018·3 cites·13 claims
- 1388US10010515B2Therapeutic approaches for treating Parkinson's diseasePHARNEXT·Filed 2016·Granted Jul 3, 2018·3 cites·20 claims
- 1488US9931326B2Composition comprising torasemide and baclofen for treating neurological disordersPHARNEXT·Filed 2014·Granted Apr 3, 2018·5 cites·6 claims
- 1587US10463640B2Therapeutic approaches for treating CMT and related disordersPHARNEXT·Filed 2018·Granted Nov 5, 2019·1 cites·9 claims
- 1687US10441558B2Therapeutic approaches for treating CMT and related disordersPHARNEXT·Filed 2018·Granted Oct 15, 2019·1 cites·9 claims
- 1786US10342768B2Therapeutic approaches for treating Parkinson's diseasePHARNEXT·Filed 2015·Granted Jul 9, 2019·2 cites·24 claims
- 1885US10905686B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2018·Granted Feb 2, 2021·1 cites·25 claims
- 1985US10300015B2Stable oral solutions for combined APIPHARNEXT·Filed 2014·Granted May 28, 2019·8 cites·20 claims
- 2085US9387206B2Therapeutic approaches for treating Alzheimer's diseasePHARNEXT·Filed 2014·Granted Jul 12, 2016·3 cites·8 claims
- 2185US9248111B2Therapeutic approaches for treating parkinson's diseasePHARNEXT·Filed 2014·Granted Feb 2, 2016·6 cites·23 claims
- 2283US10583135B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2016·Granted Mar 10, 2020·1 cites·24 claims
- 2382US10849851B2Stable oral solutions for combined APIPHARNEXT·Filed 2019·Granted Dec 1, 2020·1 cites·35 claims
- 2482US2023233552A1Compositions for treating cmt and related disordersPHARNEXT·Filed 2023·Application pending·0 cites
- 2581US10940147B2Early treatment of CMT diseasePHARNEXT·Filed 2019·Granted Mar 9, 2021·1 cites·18 claims
- 2681US10434109B2Compositions for treating neurological disordersPHARNEXT·Filed 2018·Granted Oct 8, 2019·2 cites·7 claims
- 2779US10383870B2Early treatment of CMT diseasePHARNEXT·Filed 2017·Granted Aug 20, 2019·1 cites·17 claims
- 2879US10004744B2Therapeutic approaches for treating Parkinson's diseasePHARNEXT·Filed 2013·Granted Jun 26, 2018·3 cites·12 claims
- 2979US9867837B2Compositions for treating neurological disordersPHARNEXT·Filed 2013·Granted Jan 16, 2018·3 cites·9 claims
- 3077US2020155491A1Therapeutic approaches for treating cmt and related disordersPHARNEXT·Filed 2019·Application pending·0 cites
- 3175US11672796B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2020·Granted Jun 13, 2023·0 cites·25 claims
- 3275US10682342B2Compositions for treating amyotrophic lateral sclerosisPHARNEXT·Filed 2019·Granted Jun 16, 2020·0 cites·14 claims
- 3373US10905672B2Combination of baclofen, acamprosate and medium chain triglycerides for the treatment of neurological disordersPHARNEXT·Filed 2015·Granted Feb 2, 2021·1 cites·15 claims
- 3472US11576908B2Compositions for treating CMT and related disordersPHARNEXT·Filed 2020·Granted Feb 14, 2023·0 cites·17 claims
- 3572US10874644B2Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse functionPHARNEXT·Filed 2019·Granted Dec 29, 2020·0 cites·7 claims
- 3672US10799499B2Combinatorial therapies of neurological disordersPHARNEXT·Filed 2017·Granted Oct 13, 2020·1 cites·19 claims
- 3772US9597297B2Combination of pilocarpin and methimazol for treating Charcot-Marietooth disease and related disordersPHARNEXT·Filed 2014·Granted Mar 21, 2017·1 cites·9 claims
- 3871US10350195B2Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse functionPHARNEXT·Filed 2015·Granted Jul 16, 2019·1 cites·6 claims
- 3970US9545389B2Baclofen and acamprosate based therapy of macular degeneration disordersPHARNEXT·Filed 2013·Granted Jan 17, 2017·1 cites·10 claims
- 4069US2020085790A1Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2019·Application pending·0 cites
- 4168US12226413B2Early treatment of CMT diseasePHARNEXT·Filed 2021·Granted Feb 18, 2025·0 cites·25 claims
- 4265US2018209997A1Diagnostic tools for charcot-marie-tooth diseasePHARNEXT·Filed 2018·Application pending·0 cites
- 4364US10617689B2Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose levelPHARNEXT·Filed 2016·Granted Apr 14, 2020·0 cites·20 claims
- 4464US2020222409A1Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose levelPHARNEXT·Filed 2020·Application pending·0 cites
- 4563US2015157626A1Therapeutic approaches for treating cmt and related disordersPHARNEXT·Filed 2015·Application pending·0 cites
- 4662US2017231958A1Baclofen and acamprosate based therapy of neurological disordersPHARNEXT·Filed 2017·Application pending·0 cites
- 4762US2021069135A1Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesisPHARNEXT·Filed 2020·Application pending·0 cites
- 4861US9945876B2Diagnostic tools for charcot-marie-tooth diseasePHARNEXT·Filed 2015·Granted Apr 17, 2018·0 cites·12 claims
- 4961US2015374647A1Therapeutic approaches for treating epilepsy and related disorders through reduction of epileptogenesisPHARNEXT·Filed 2013·Application pending·0 cites
- 5058US9789098B2Nootropic compositions for improving memory performancePHARNEXT·Filed 2013·Granted Oct 17, 2017·0 cites·12 claims
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PHARNEXT files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →